Index S&P 500
P/E 36.40
EPS (ttm) 2.10
Insider Own 1.28%
Shs Outstand 241.71M
Perf Week 1.57%
Market Cap 17.97B
Forward P/E 17.37
EPS next Y 4.41
Insider Trans -3.94%
Shs Float 231.72M
Perf Month -1.02%
Income 515.10M
PEG 4.92
EPS next Q 0.98
Inst Own 98.20%
Short Float 1.95%
Perf Quarter 2.89%
Sales 3.97B
P/S 4.53
EPS this Y 1.93%
Inst Trans -9.76%
Short Ratio 2.54
Perf Half Y 14.92%
Book/sh 19.84
P/B 3.86
EPS next Y 9.20%
ROA 5.80%
Short Interest 4.52M
Perf Year -8.41%
Cash/sh 8.23
P/C 9.30
EPS next 5Y 7.40%
ROE 10.57%
52W Range 64.02 - 87.88
Perf YTD 7.15%
Dividend Est. -
P/FCF 20.93
EPS past 5Y -
ROI 7.16%
52W High -12.88%
Beta 1.01
Dividend TTM -
Quick Ratio 3.18
Sales past 5Y 7.03%
Gross Margin 54.59%
52W Low 19.59%
ATR (14) 1.28
Dividend Ex-Date -
Current Ratio 3.89
EPS Y/Y TTM -46.37%
Oper. Margin 22.78%
RSI (14) 51.34
Volatility 1.74% 1.61%
Employees 6990
Debt/Eq 0.55
Sales Y/Y TTM -11.12%
Profit Margin 12.98%
Recom 2.05
Target Price 85.29
Option/Short Yes / Yes
LT Debt/Eq 0.55
EPS Q/Q 36.50%
Payout 0.00%
Rel Volume 0.29
Prev Close 75.71
Sales Surprise 2.40%
EPS Surprise 3.17%
Sales Q/Q -5.69%
Earnings May 02 AMC
Avg Volume 1.78M
Price 76.56
SMA20 -0.27%
SMA50 0.89%
SMA200 4.37%
Trades
Volume 446,539
Change 1.12%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-03-24 Upgrade
Citigroup
Neutral → Buy
$80 → $95
Jul-14-23 Upgrade
Needham
Hold → Buy
$95
Dec-07-22 Initiated
RBC Capital Mkts
Sector Perform
$75
Oct-13-22 Initiated
Mizuho
Buy
$75
Jul-20-22 Initiated
UBS
Neutral
$73
Jul-20-22 Downgrade
BofA Securities
Buy → Neutral
$81 → $75
Jul-18-22 Downgrade
BTIG Research
Buy → Neutral
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$75
Apr-04-22 Downgrade
Evercore ISI
Outperform → In-line
$80
Dec-15-21 Downgrade
Citigroup
Buy → Neutral
$85 → $78
Oct-15-21 Resumed
Cowen
Outperform
$83
Oct-14-21 Initiated
Redburn
Neutral
Jul-06-21 Upgrade
Evercore ISI
In-line → Outperform
$78
Nov-20-20 Downgrade
Needham
Buy → Hold
Nov-05-20 Reiterated
Needham
Buy
$78 → $88
Jun-30-20 Upgrade
Cowen
Market Perform → Outperform
$64
Jun-03-20 Upgrade
Raymond James
Mkt Perform → Outperform
$62
Apr-30-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$62
Apr-30-20 Reiterated
Needham
Buy
$52 → $60
Apr-07-20 Upgrade
Wells Fargo
Equal Weight → Overweight
$48
Show Previous Ratings
Apr-25-24 10:01AM
Apr-22-24 05:45PM
Apr-21-24 08:30AM
Apr-19-24 11:30AM
09:00AM
11:01AM
Loading…
Apr-17-24 11:01AM
Apr-15-24 05:45PM
Apr-12-24 10:45AM
Apr-11-24 02:07PM
09:15AM
Apr-08-24 05:45PM
09:00AM
Apr-03-24 12:10PM
09:54AM
Apr-02-24 05:45PM
08:08AM
Loading…
08:08AM
Mar-28-24 07:24AM
Mar-27-24 09:00AM
Mar-25-24 05:45PM
Mar-19-24 12:53PM
(The Wall Street Journal)
Mar-18-24 05:45PM
Mar-15-24 07:00PM
09:00AM
Mar-12-24 05:45PM
Mar-06-24 11:15AM
Mar-05-24 08:10AM
Mar-04-24 09:00AM
Feb-28-24 01:16AM
Feb-27-24 03:44PM
03:30PM
08:00AM
Loading…
08:00AM
Feb-26-24 04:15PM
Feb-21-24 09:00AM
Feb-18-24 01:26PM
Feb-06-24 10:43AM
Feb-05-24 03:31PM
01:43PM
10:40AM
09:00AM
Feb-03-24 12:08AM
Feb-02-24 12:52PM
11:08AM
07:05AM
(Thomson Reuters StreetEvents)
Feb-01-24 05:35PM
05:30PM
05:21PM
04:45PM
04:10PM
(Associated Press Finance)
04:01PM
Jan-31-24 11:17AM
Jan-30-24 07:29PM
Jan-29-24 09:16AM
Jan-25-24 11:00AM
(The Wall Street Journal)
10:00AM
Jan-22-24 05:45PM
Jan-20-24 03:19PM
Jan-19-24 09:00AM
Jan-18-24 11:30AM
Jan-17-24 12:10PM
12:07PM
Jan-16-24 05:45PM
08:30AM
Jan-11-24 08:08AM
Jan-09-24 05:45PM
Jan-08-24 09:00AM
Jan-07-24 04:00PM
Jan-04-24 08:33AM
Jan-02-24 05:45PM
08:08AM
Dec-28-23 04:28AM
Dec-27-23 05:45PM
09:00AM
Dec-20-23 05:45PM
Dec-18-23 07:39AM
Dec-14-23 05:45PM
05:05PM
Dec-11-23 06:55AM
Dec-07-23 03:37AM
Dec-05-23 09:00AM
Dec-03-23 05:25AM
Dec-01-23 06:25AM
Nov-30-23 06:00AM
Nov-28-23 05:27PM
Nov-25-23 03:04AM
Nov-24-23 09:00AM
08:05AM
Nov-22-23 12:13AM
Nov-21-23 08:15AM
Nov-14-23 05:03PM
Nov-13-23 09:00AM
Nov-10-23 05:12PM
03:41PM
01:02PM
12:18PM
(Associated Press Finance)
12:01PM
09:02AM
08:37AM
07:30AM
(Thomson Reuters StreetEvents)
Nov-09-23 05:30PM
04:22PM
(Associated Press Finance)
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products dedicated to serve the healthcare needs of women. It operates through the following segments: Breast Health, Diagnostics, GYN Surgical, and Skeletal Health. The Breast Health segment is involved in a portfolio of solutions for breast cancer care for radiology, pathology, and surgery. The Diagnostics segment focuses on products used to aid in the screening and diagnosis of human diseases. The GYN Surgical segment offers the NovaSure Endometrial Ablation System, the MyoSure Hysteroscopic Tissue Removal System, and the Fluent Fluid Management System. The Skeletal Health segment covers the Horizon DXA and the Fluoroscan Insight FD mini C-arm. The company was founded by S. David Ellenbogen and Jay A. Stein in 1985 and is headquartered in Marlborough, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
GARRETT SCOTT T Director Mar 14 '24 Option Exercise 30.93 16,441 508,471 65,052 Mar 15 04:11 PM GARRETT SCOTT T Director Mar 14 '24 Sale 75.50 16,441 1,241,296 48,611 Mar 15 04:11 PM CRAWFORD SALLY Director Mar 08 '24 Option Exercise 26.74 9,039 241,703 141,966 Mar 11 06:41 PM CRAWFORD SALLY Director Mar 08 '24 Sale 76.40 9,039 690,607 132,927 Mar 11 06:41 PM Dockendorff Charles J Director Mar 08 '24 Sale 76.21 1,465 111,648 1,572 Mar 11 06:45 PM Oberton Karleen Marie Chief Financial Officer Jan 29 '24 Sale 75.00 14,940 1,120,500 103,916 Jan 30 04:08 PM Dockendorff Charles J Director Jan 02 '24 Option Exercise 38.44 7,551 290,260 17,482 Jan 04 04:09 PM Dockendorff Charles J Director Jan 02 '24 Sale 72.00 16,017 1,153,224 1,465 Jan 04 04:09 PM GARRETT SCOTT T Director Dec 11 '23 Sale 68.71 10,000 687,116 47,039 Dec 13 04:07 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Option Exercise 26.21 47,711 1,250,505 1,286,799 Dec 01 04:04 PM MACMILLAN STEPHEN P Chairman, President and CEO Nov 29 '23 Sale 70.41 47,711 3,359,188 1,239,088 Dec 01 04:04 PM Mitchell Essex D Div. President, GYN Surgical Nov 21 '23 Sale 71.85 7,500 538,890 12,827 Nov 24 04:02 PM GARRETT SCOTT T Director Jun 15 '23 Sale 79.72 10,000 797,240 57,039 Jun 20 05:03 PM Mitchell Essex D Div. President, GYN Surgical May 05 '23 Sale 83.73 2,390 200,115 7,212 May 09 04:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite